In particular, we found that 72 (72.7%) out of 99 patients (Tables 4 and 5) were positive to caspase-4, according to a cut-off value of 0.377 ng/ml, which represented the mean value of the 95% CI of non-COPD, non-lung cancer tissues. Here, CASP4 is linked to lung cancer.